×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NWBO – northwest biothrputcs inc (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NWBO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/14
03:44 am
nwbo
Northwest Biotherapeutics: All Is Not Well With This One [Seeking Alpha]
Medium
Report
Northwest Biotherapeutics: All Is Not Well With This One [Seeking Alpha]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
9/4
NW Bio Expands Senior Management Team With Dr. Kevin Duffy As Vice President, Medical Affairs & External Collaborations
31.0%
6/4 Highlights Of NW Bio's Program Update In The Industry Expert Theater Presentation At ASCO 11.1%
1/25 Presentation By NWBio CEO At The Phacilitate Leaders World 2019 Conference 7.1%
12/12 Northwest Biotherapeutics (OTCQB:NWBO) Further Expands Senior Management Team 6.3%
11/1 Form EFFECT NORTHWEST BIOTHERAPEUTIC 6.0%
5/30 NW Bio To Present Updates On DCVax® Clinical Programs In Industry Theater Presentation At ASCO 5.9%
5/28 NW Bio Announces Settlement with Cognate BioServices Resolving Past Matters and Providing for Restart of DCVax®-Direct Production 1.8%
2/26 NW Bio Hires David Innes As Vice President, Investor Relations 0.7%
8/9 Form 10-Q NORTHWEST BIOTHERAPEUTIC For: Jun 30 0.5%
12/11 Northwest Biotherapeutics (OTCQB; NWBO) Announces Presentation At Inaugural Glioblastoma Drug Development Summit 0.2%
6/4 Highlights Of NW Bio's Program Update In The Industry Expert Theater Presentation At ASCO 11.1%
1/25 Presentation By NWBio CEO At The Phacilitate Leaders World 2019 Conference 7.1%
12/12 Northwest Biotherapeutics (OTCQB:NWBO) Further Expands Senior Management Team 6.3%
11/1 Form EFFECT NORTHWEST BIOTHERAPEUTIC 6.0%
5/30 NW Bio To Present Updates On DCVax® Clinical Programs In Industry Theater Presentation At ASCO 5.9%
5/28 NW Bio Announces Settlement with Cognate BioServices Resolving Past Matters and Providing for Restart of DCVax®-Direct Production 1.8%
2/26 NW Bio Hires David Innes As Vice President, Investor Relations 0.7%
8/9 Form 10-Q NORTHWEST BIOTHERAPEUTIC For: Jun 30 0.5%
12/11 Northwest Biotherapeutics (OTCQB; NWBO) Announces Presentation At Inaugural Glioblastoma Drug Development Summit 0.2%
TOP News Decliners
3/19
Form NT 10-K NORTHWEST BIOTHERAPEUTIC For: Dec 31
-7.4%
1/3 Form 424B5 NORTHWEST BIOTHERAPEUTIC -4.8%
7/17 Form 424B5 NORTHWEST BIOTHERAPEUTIC -3.4%
1/29 Form 4 NORTHWEST BIOTHERAPEUTIC For: Dec 27 Filed by: Powers Linda F -2.5%
11/12 Q3/2019 9/30/2019 EPS -0.010 ZacksConsensus N/A ActVsEst N/A - N/A -2.0%
1/15 Form 424B5 NORTHWEST BIOTHERAPEUTIC -1.9%
7/22 Form 8-K NORTHWEST BIOTHERAPEUTIC For: Jul 16 -1.4%
12/20 Form 3 NORTHWEST BIOTHERAPEUTIC For: Dec 09 Filed by: DAVIS JEAN M. -1.4%
1/24 Northwest Biotherapeutics, Inc (OTCMKTS: NWBO) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -1.1%
5/10 Form 10-Q NORTHWEST BIOTHERAPEUTIC For: Mar 31 -0.9%
1/3 Form 424B5 NORTHWEST BIOTHERAPEUTIC -4.8%
7/17 Form 424B5 NORTHWEST BIOTHERAPEUTIC -3.4%
1/29 Form 4 NORTHWEST BIOTHERAPEUTIC For: Dec 27 Filed by: Powers Linda F -2.5%
11/12 Q3/2019 9/30/2019 EPS -0.010 ZacksConsensus N/A ActVsEst N/A - N/A -2.0%
1/15 Form 424B5 NORTHWEST BIOTHERAPEUTIC -1.9%
7/22 Form 8-K NORTHWEST BIOTHERAPEUTIC For: Jul 16 -1.4%
12/20 Form 3 NORTHWEST BIOTHERAPEUTIC For: Dec 09 Filed by: DAVIS JEAN M. -1.4%
1/24 Northwest Biotherapeutics, Inc (OTCMKTS: NWBO) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -1.1%
5/10 Form 10-Q NORTHWEST BIOTHERAPEUTIC For: Mar 31 -0.9%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: